Lancet peer review confirms performance of country’s flagship two-shot jab
Home/FT/Russia’s Sputnik vaccine shows 91.6% efficacy in clinical trials FT Russia’s Sputnik vaccine shows 91.6% efficacy in clinical trials Financial Times0 Less than a minute Facebook X LinkedIn Lancet peer review confirms performance of country’s flagship two-shot jab Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
